| Absorption |
| Blood-Brain Barrier | BBB+ | 0.9727 |
| Human Intestinal Absorption | HIA+ | 1.0000 |
| Caco-2 Permeability | Caco2+ | 0.8654 |
| P-glycoprotein Substrate | Substrate | 0.5901 |
| P-glycoprotein Inhibitor | Inhibitor | 0.5668 |
| Non-inhibitor | 0.6612 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.7086 |
| Distribution |
| Subcellular localization | Mitochondria | 0.7226 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.8066 |
| CYP450 2D6 Substrate | Non-substrate | 0.8711 |
| CYP450 3A4 Substrate | Substrate | 0.7939 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.7489 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.8774 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.9540 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.6545 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.8094 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.8393 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.8667 |
| Non-inhibitor | 0.7555 |
| AMES Toxicity | Non AMES toxic | 0.9567 |
| Carcinogens | Non-carcinogens | 0.9316 |
| Fish Toxicity | High FHMT | 0.9792 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.9690 |
| Honey Bee Toxicity | High HBT | 0.8651 |
| Biodegradation | Not ready biodegradable | 0.9529 |
| Acute Oral Toxicity | III | 0.7929 |
| Carcinogenicity (Three-class) | Warning | 0.4754 |